Free Trial

10 Best Penny Stocks to Buy Now - 3 of 10

 
 

Outset Medical (NASDAQ:OM)

Number of Upgrades from Top-Ranked Analysts
4 (in the last 90 days)
Consensus Rating
Hold
Rating Score
2.4
Ratings Breakdown
4 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$4.64 (585.8% Upside)

About Outset Medical

Outset Medical logoOutset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/8/2024TD CowenLower Price TargetBuy ➝ Buy$9.00 ➝ $3.00
8/8/2024Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$6.00 ➝ $3.00
6/21/2024Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$5.00 ➝ $6.00
4/8/2024BTIG ResearchInitiated CoverageBuy$6.00
4/5/2024CL KingUpgradeNeutral ➝ Buy$6.00
1/12/2024Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$14.00 ➝ $6.00
12/4/2023Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$5.00 ➝ $5.50
11/14/2023Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$19.00 ➝ $5.00
10/13/2023Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$29.00 ➝ $17.00
10/13/2023Stifel NicolausLower Price TargetBuy ➝ Buy$26.00 ➝ $6.00
 

Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade